サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1442869

獣医分子診断市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年～2031年

Veterinary Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 250 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
獣医分子診断市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年～2031年
出版日: 2024年01月30日
発行: Transparency Market Research
ページ情報: 英文 250 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

獣医分子診断市場 - レポートの範囲

世界の獣医分子診断市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、世界の獣医用分子診断の収益を提供します。 2023年を基準年、2031年を予測年とみなして、2017年から2031年の期間の市場を分析します。レポートは、2023年から2031年までの世界の獣医学分子診断市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、獣医学分子診断市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

このレポートは、世界の獣医分子診断市場の競合情勢を詳しく調査しています。世界の獣医分子診断市場で活動する主要企業が特定され、それぞれの企業がさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の獣医分子診断市場の企業の属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2017～2031年

第5章 重要な洞察

  • パイプライン分析
  • 主要製品/ブランド分析
  • 主な合併と買収
  • COVID-19感染症のパンデミックが業界に与える影響

第6章 世界市場の分析と予測：製品タイプ別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：製品タイプ別、2017年～2031年
    • 機器とソフトウェア
    • キットと試薬
    • サービス
  • 市場の魅力度：製品タイプ別

第7章 世界市場の分析と予測：技術別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：技術別、2017年～2031年
    • 従来のPCR
    • シングルプレックス PCR
    • マルチプレックス PCR
    • リアルタイムPCR
    • その他
    • 7.4市場の魅力：技術別

第8章 世界市場の分析と予測：疾患タイプ別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：疾患タイプ別、2017年～2031年
    • ベクター媒介疾患
    • 呼吸器病原体
    • 下痢の病原体
    • その他
  • 市場魅力度：疾患タイプ別

第9章 世界市場の分析と予測：動物タイプ別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：動物タイプ別、2017年～2031年
    • コンパニオンアニマル
    • 家畜
  • 市場の魅力度：動物タイプ別

第10章 世界市場の分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：エンドユーザー別、2017年～2031年
    • 病院・診療所
    • リファレンスラボ
  • 市場の魅力度：エンドユーザー別

第11章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2017年～2031年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力：地域別

第12章 北米市場の分析と予測

第13章 欧州市場の分析と予測

第14章 アジア太平洋市場の分析と予測

第15章 ラテンアメリカ市場の分析と予測

第16章 中東・アフリカ市場の分析と予測

第17章 競合情勢

  • 市場プレーヤー-競合マトリックス（企業の階層および規模別）
  • 市場シェア分析：企業別（2022年）
  • 企業プロファイル
    • IDEXX Laboratories, Inc.
    • Thermo Fisher Scientific, Inc.
    • Zoetis, Inc.
    • Neogen Corporation
    • bioMerieux SA
    • QIAGEN NV
    • Biomedica Medizinprodukte GmbH
    • Bioneer
    • Mars, Incorporated
    • Innovative Diagnostics
図表

List of Tables

  • Table 01: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 03: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017-2031
  • Table 04: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017-2031
  • Table 05: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 06: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 08: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 09: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 10: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017-2031
  • Table 11: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017-2031
  • Table 12: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 15: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 16: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017-2031
  • Table 17: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017-2031
  • Table 18: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 19: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 20: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 21: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 22: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017-2031
  • Table 23: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017-2031
  • Table 24: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 27: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 28: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017-2031
  • Table 29: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017-2031
  • Table 30: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 31: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 32: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 33: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 34: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017-2031
  • Table 35: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017-2031
  • Table 36: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2022-2031
  • Figure 02: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by Product Type, 2022
  • Figure 03: Global Veterinary Molecular Diagnostics Market Value Share, by Product Type, 2022
  • Figure 04: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by Technology, 2022
  • Figure 05: Global Veterinary Molecular Diagnostics Market Value Share, by Technology, 2022
  • Figure 06: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), By Disease Type, 2022
  • Figure 07: Global Veterinary Molecular Diagnostics Market Value Share, By Disease Type, 2022
  • Figure 08: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by Animal Type, 2022
  • Figure 09: Global Veterinary Molecular Diagnostics Market Value Share, by Animal Type, 2022
  • Figure 10: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by End-user, 2022
  • Figure 11: Global Veterinary Molecular Diagnostics Market Value Share, by End-user, 2022
  • Figure 12: Global Veterinary Molecular Diagnostics Market Value Share, by Region, 2022
  • Figure 13: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 14: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 15: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 16: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022-2031
  • Figure 17: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 18: Global Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022-2031
  • Figure 19: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023-2031
  • Figure 20: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by Animal Type, 2022
  • Figure 21: Global Veterinary Molecular Diagnostics Market Value Share, by Animal Type, 2022
  • Figure 22: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by End-user, 2022
  • Figure 23: Global Veterinary Molecular Diagnostics Market Value Share, by End-user, 2022
  • Figure 24: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Region, 2022-2031
  • Figure 25: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 26: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 27: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 28: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Country, 2022-2031
  • Figure 29: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 30: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022-2031
  • Figure 31: North America Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022-2031
  • Figure 32: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2022-2031
  • Figure 33: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by User End-user, 2022-2031
  • Figure 34: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 35: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 36: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023-2031
  • Figure 37: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2023-2031
  • Figure 38: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 39: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 40: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 41: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 42: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 43: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022-2031
  • Figure 44: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022-2031
  • Figure 45: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2022-2031
  • Figure 46: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by User End-user, 2022-2031
  • Figure 47: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 48: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 49: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023-2031
  • Figure 50: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2023-2031
  • Figure 51: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 52: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 53: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 54: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 55: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 56: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022-2031
  • Figure 57: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022-2031
  • Figure 58: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2022-2031
  • Figure 59: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by User End-user, 2022-2031
  • Figure 60: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 61: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 62: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023-2031
  • Figure 63: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2023-2031
  • Figure 64: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 65: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 66: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 67: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 68: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 69: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022-2031
  • Figure 70: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022-2031
  • Figure 71: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2022-2031
  • Figure 72: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by User End-user, 2022-2031
  • Figure 73: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 74: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 75: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023-2031
  • Figure 76: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2023-2031
  • Figure 77: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 78: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 79: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 80: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 81: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 82: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022-2031
  • Figure 83: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022-2031
  • Figure 84: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2022-2031
  • Figure 85: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by User End-user, 2022-2031
  • Figure 86: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 87: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 88: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023-2031
  • Figure 89: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2023-2031
  • Figure 90: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
目次
Product Code: TMRGL42437

Veterinary Molecular Diagnostics Market - Scope of Report

TMR's report on the global veterinary molecular diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global veterinary molecular diagnostics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global veterinary molecular diagnostics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the veterinary molecular diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global veterinary molecular diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global veterinary molecular diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global veterinary molecular diagnostics market.

The report delves into the competitive landscape of the global veterinary molecular diagnostics market. Key players operating in the global veterinary molecular diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global veterinary molecular diagnostics market profiled in this report.

Key Questions Answered in Global veterinary molecular diagnostics market Report:

  • What is the sales/revenue generated by wearable injectors across all regions during the forecast period?
  • What are the opportunities in the global veterinary molecular diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Veterinary Molecular Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global veterinary molecular diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global veterinary molecular diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global veterinary molecular diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Veterinary Molecular Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, by Product Type

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Instruments & Software
    • 6.3.2. Kits & Reagents
    • 6.3.3. Services
  • 6.4. Market Attractiveness, by Product Type

7. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, by Technology

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technology, 2017-2031
    • 7.3.1. Conventional PCR
    • 7.3.2. Singleplex PCR
    • 7.3.3. Multiplex PCR
    • 7.3.4. Real-time PCR
    • 7.3.5. Others
    • 7.3.6. 7.4 Market Attractiveness, by Technology

8. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, By Disease Type

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, By Disease Type, 2017-2031
    • 8.3.1. Vector-borne Diseases
    • 8.3.2. Respiratory Pathogens
    • 8.3.3. Diarrhea Pathogens
    • 8.3.4. Others
  • 8.4. Market Attractiveness, By Disease Type

9. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, by Animal Type

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Animal Type, 2017-2031
    • 9.3.1. Companion Animal
    • 9.3.2. Livestock Animal
  • 9.4. Market Attractiveness, by Animal Type

10. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, by End-user

  • 10.1. Introduction and Definitions
  • 10.2. Key Findings/Developments
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Hospitals/Clinics
    • 10.3.2. Reference Laboratories
  • 10.4. Market Attractiveness, by End-user

11. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region, 2017-2031
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness, by Region

12. North America Veterinary Molecular Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. Instruments & Software
    • 12.2.2. Kits & Reagents
    • 12.2.3. Services
  • 12.3. Market Attractiveness, by Product Type
  • 12.4. Market Value Forecast, by Technology, 2017-2031
    • 12.4.1. Conventional PCR
    • 12.4.2. Singleplex PCR
    • 12.4.3. Multiplex PCR
    • 12.4.4. Real-time PCR
    • 12.4.5. Others
  • 12.5. Market Attractiveness, by Technology
  • 12.6. Market Value Forecast, By Disease Type, 2017-2031
    • 12.6.1. Vector-borne Diseases
    • 12.6.2. Respiratory Pathogens
    • 12.6.3. Diarrhea Pathogens
    • 12.6.4. Others
  • 12.7. Market Attractiveness, By Disease Type
  • 12.8. Market Value Forecast, by Animal Type, 2017-2031
    • 12.8.1. Companion Animal
    • 12.8.2. Livestock Animal
  • 12.9. Market Attractiveness, by Animal Type
  • 12.10. Market Value Forecast, by User End-user, 2017-2031
    • 12.10.1. Hospitals/Clinics
    • 12.10.2. Reference Laboratories
  • 12.11. Market Attractiveness, by End-user
  • 12.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.12.1. U.S.
    • 12.12.2. Canada
  • 12.13. Market Attractiveness Analysis
    • 12.13.1. By Product Type
    • 12.13.2. By Technology
    • 12.13.3. By Disease Type
    • 12.13.4. By Animal Type
    • 12.13.5. By End-user
    • 12.13.6. By Country

13. Europe Veterinary Molecular Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. Instruments & Software
    • 13.2.2. Kits & Reagents
    • 13.2.3. Services
  • 13.3. Market Attractiveness, by Product Type
  • 13.4. Market Value Forecast, by Technology, 2017-2031
    • 13.4.1. Conventional PCR
    • 13.4.2. Singleplex PCR
    • 13.4.3. Multiplex PCR
    • 13.4.4. Real-time PCR
    • 13.4.5. Others
  • 13.5. Market Attractiveness, by Technology
  • 13.6. Market Value Forecast, By Disease Type, 2017-2031
    • 13.6.1. Vector-borne Diseases
    • 13.6.2. Respiratory Pathogens
    • 13.6.3. Diarrhea Pathogens
    • 13.6.4. Others
  • 13.7. Market Attractiveness, By Disease Type
  • 13.8. Market Value Forecast, by Animal Type, 2017-2031
    • 13.8.1. Companion Animal
    • 13.8.2. Livestock Animal
  • 13.9. Market Attractiveness, by Animal Type
  • 13.10. Market Value Forecast, by User End-user, 2017-2031
    • 13.10.1. Hospitals/Clinics
    • 13.10.2. Reference Laboratories
  • 13.11. Market Attractiveness, by End-user
  • 13.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.12.1. Germany
    • 13.12.2. U.K.
    • 13.12.3. France
    • 13.12.4. Italy
    • 13.12.5. Spain
    • 13.12.6. Rest of Europe
  • 13.13. Market Attractiveness Analysis
    • 13.13.1. By Product Type
    • 13.13.2. By Technology
    • 13.13.3. By Disease Type
    • 13.13.4. By Animal Type
    • 13.13.5. By End-user
    • 13.13.6. By Country/Sub-region

14. Asia Pacific Veterinary Molecular Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2017-2031
    • 14.2.1. Instruments & Software
    • 14.2.2. Kits & Reagents
    • 14.2.3. Services
  • 14.3. Market Attractiveness, by Product Type
  • 14.4. Market Value Forecast, by Technology, 2017-2031
    • 14.4.1. Conventional PCR
    • 14.4.2. Singleplex PCR
    • 14.4.3. Multiplex PCR
    • 14.4.4. Real-time PCR
    • 14.4.5. Others
  • 14.5. Market Attractiveness, by Technology
  • 14.6. Market Value Forecast, By Disease Type, 2017-2031
    • 14.6.1. Vector-borne Diseases
    • 14.6.2. Respiratory Pathogens
    • 14.6.3. Diarrhea Pathogens
    • 14.6.4. Others
  • 14.7. Market Attractiveness, By Disease Type
  • 14.8. Market Value Forecast, by Animal Type, 2017-2031
    • 14.8.1. Companion Animal
    • 14.8.2. Livestock Animal
  • 14.9. Market Attractiveness, by Animal Type
  • 14.10. Market Value Forecast, by User End-user, 2017-2031
    • 14.10.1. Hospitals/Clinics
    • 14.10.2. Reference Laboratories
  • 14.11. Market Attractiveness, by End-user
  • 14.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.12.1. China
    • 14.12.2. Japan
    • 14.12.3. India
    • 14.12.4. Australia & New Zealand
    • 14.12.5. Rest of Asia Pacific
  • 14.13. Market Attractiveness Analysis
    • 14.13.1. By Product Type
    • 14.13.2. By Technology
    • 14.13.3. By Disease Type
    • 14.13.4. By Animal Type
    • 14.13.5. By End-user
    • 14.13.6. By Country/Sub-region

15. Latin America Veterinary Molecular Diagnostics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product Type, 2017-2031
    • 15.2.1. Instruments & Software
    • 15.2.2. Kits & Reagents
    • 15.2.3. Services
  • 15.3. Market Attractiveness, by Product Type
  • 15.4. Market Value Forecast, by Technology, 2017-2031
    • 15.4.1. Conventional PCR
    • 15.4.2. Singleplex PCR
    • 15.4.3. Multiplex PCR
    • 15.4.4. Real-time PCR
    • 15.4.5. Others
  • 15.5. Market Attractiveness, by Technology
  • 15.6. Market Value Forecast, By Disease Type, 2017-2031
    • 15.6.1. Vector-borne Diseases
    • 15.6.2. Respiratory Pathogens
    • 15.6.3. Diarrhea Pathogens
    • 15.6.4. Others
  • 15.7. Market Attractiveness, By Disease Type
  • 15.8. Market Value Forecast, by Animal Type, 2017-2031
    • 15.8.1. Companion Animal
    • 15.8.2. Livestock Animal
  • 15.9. Market Attractiveness, by Animal Type
  • 15.10. Market Value Forecast, by User End-user, 2017-2031
    • 15.10.1. Hospitals/Clinics
    • 15.10.2. Reference Laboratories
  • 15.11. Market Attractiveness, by End-user
  • 15.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.12.1. Brazil
    • 15.12.2. Mexico
    • 15.12.3. Rest of Latin America
  • 15.13. Market Attractiveness Analysis
    • 15.13.1. By Product Type
    • 15.13.2. By Technology
    • 15.13.3. By Disease Type
    • 15.13.4. By Animal Type
    • 15.13.5. By End-user
    • 15.13.6. By Country/Sub-region

16. Middle East & Africa Veterinary Molecular Diagnostics Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Product Type, 2017-2031
    • 16.2.1. Instruments & Software
    • 16.2.2. Kits & Reagents
    • 16.2.3. Services
  • 16.3. Market Attractiveness, by Product Type
  • 16.4. Market Value Forecast, by Technology, 2017-2031
    • 16.4.1. Conventional PCR
    • 16.4.2. Singleplex PCR
    • 16.4.3. Multiplex PCR
    • 16.4.4. Real-time PCR
    • 16.4.5. Others
  • 16.5. Market Attractiveness, by Technology
  • 16.6. Market Value Forecast, By Disease Type, 2017-2031
    • 16.6.1. Vector-borne Diseases
    • 16.6.2. Respiratory Pathogens
    • 16.6.3. Diarrhea Pathogens
    • 16.6.4. Others
  • 16.7. Market Attractiveness, By Disease Type
  • 16.8. Market Value Forecast, by Animal Type, 2017-2031
    • 16.8.1. Companion Animal
    • 16.8.2. Livestock Animal
  • 16.9. Market Attractiveness, by Animal Type
  • 16.10. Market Value Forecast, by User End-user, 2017-2031
    • 16.10.1. Hospitals/Clinics
    • 16.10.2. Reference Laboratories
  • 16.11. Market Attractiveness, by End-user
  • 16.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 16.12.1. GCC Countries
    • 16.12.2. South Africa
    • 16.12.3. Rest of Middle East & Africa
  • 16.13. Market Attractiveness Analysis
    • 16.13.1. By Product Type
    • 16.13.2. By Technology
    • 16.13.3. By Disease Type
    • 16.13.4. By Animal Type
    • 16.13.5. By End-user
    • 16.13.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 17.2. Market Share Analysis, by Company (2022)
  • 17.3. Company Profiles
    • 17.3.1. IDEXX Laboratories, Inc.
      • 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.1.2. Product Portfolio
      • 17.3.1.3. Financial Overview
      • 17.3.1.4. SWOT Analysis
      • 17.3.1.5. Strategic Overview
    • 17.3.2. Thermo Fisher Scientific, Inc.
      • 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.2.2. Product Portfolio
      • 17.3.2.3. Financial Overview
      • 17.3.2.4. SWOT Analysis
      • 17.3.2.5. Strategic Overview
    • 17.3.3. Zoetis, Inc.
      • 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.3.2. Product Portfolio
      • 17.3.3.3. Financial Overview
      • 17.3.3.4. SWOT Analysis
      • 17.3.3.5. Strategic Overview
    • 17.3.4. Neogen Corporation
      • 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.4.2. Product Portfolio
      • 17.3.4.3. Financial Overview
      • 17.3.4.4. SWOT Analysis
      • 17.3.4.5. Strategic Overview
    • 17.3.5. bioMerieux SA
      • 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.5.2. Product Portfolio
      • 17.3.5.3. Financial Overview
      • 17.3.5.4. SWOT Analysis
      • 17.3.5.5. Strategic Overview
    • 17.3.6. QIAGEN N.V.
      • 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.6.2. Product Portfolio
      • 17.3.6.3. Financial Overview
      • 17.3.6.4. SWOT Analysis
      • 17.3.6.5. Strategic Overview
    • 17.3.7. Biomedica Medizinprodukte GmbH
      • 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.7.2. Product Portfolio
      • 17.3.7.3. Financial Overview
      • 17.3.7.4. SWOT Analysis
      • 17.3.7.5. Strategic Overview
    • 17.3.8. Bioneer
      • 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.8.2. Product Portfolio
      • 17.3.8.3. Financial Overview
      • 17.3.8.4. SWOT Analysis
      • 17.3.8.5. Strategic Overview
    • 17.3.9. Mars, Incorporated
      • 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.9.2. Product Portfolio
      • 17.3.9.3. Financial Overview
      • 17.3.9.4. SWOT Analysis
      • 17.3.9.5. Strategic Overview
    • 17.3.10. Innovative Diagnostics
      • 17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.10.2. Product Portfolio
      • 17.3.10.3. Financial Overview
      • 17.3.10.4. SWOT Analysis
      • 17.3.10.5. Strategic Overview